UY27365A1 - Vacuna de mycoplasma bovis y métodos para reducir la neumonía en animales - Google Patents

Vacuna de mycoplasma bovis y métodos para reducir la neumonía en animales

Info

Publication number
UY27365A1
UY27365A1 UY27365A UY27365A UY27365A1 UY 27365 A1 UY27365 A1 UY 27365A1 UY 27365 A UY27365 A UY 27365A UY 27365 A UY27365 A UY 27365A UY 27365 A1 UY27365 A1 UY 27365A1
Authority
UY
Uruguay
Prior art keywords
mycoplasma bovis
vaccine
methods
animals
vaccines
Prior art date
Application number
UY27365A
Other languages
English (en)
Inventor
R Keich
D Mcgavin
R Yancey
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY27365A1 publication Critical patent/UY27365A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La invención: a) refiere a vacunas de Mycoplasma bovis y procedimentos para tratar o prevenir enfermedad o trastorno en un animal causado por infección con Mycoplasma bovis, administrando al animal una cantidad efectiva de una vacuna de Mycoplasma bovis. La misma puede ser una preparación de células totales o parciales inactivas o vivas modificadas, una vacuna de subunidades, o una vacuna de ácido nucleico o ADN. La vacuna de Myclopasma bovis administrada de acuerdo con la presente se puede producir por síntesis o de manera recombinante. b) refiere a vacunas de combinación, procedimientos para la preparación de vacunas de Mycoplasma bovis y kits.
UY27365A 2001-07-02 2002-07-01 Vacuna de mycoplasma bovis y métodos para reducir la neumonía en animales UY27365A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
UY27365A1 true UY27365A1 (es) 2003-04-30

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27365A UY27365A1 (es) 2001-07-02 2002-07-01 Vacuna de mycoplasma bovis y métodos para reducir la neumonía en animales

Country Status (31)

Country Link
US (1) US20030147914A1 (es)
EP (1) EP1401488A1 (es)
JP (1) JP2004536106A (es)
KR (1) KR20040030783A (es)
CN (1) CN1522152A (es)
AP (1) AP2002002568A0 (es)
AR (1) AR036125A1 (es)
BG (1) BG108496A (es)
BR (1) BR0210798A (es)
CA (1) CA2452580A1 (es)
CZ (1) CZ20033465A3 (es)
EA (1) EA200301324A1 (es)
GT (1) GT200200139A (es)
HN (1) HN2002000162A (es)
HR (1) HRP20031078A2 (es)
HU (1) HUP0501188A2 (es)
IL (1) IL159516A0 (es)
IS (1) IS7078A (es)
MA (1) MA27048A1 (es)
MX (1) MXPA03011815A (es)
NO (1) NO20035767L (es)
OA (1) OA12640A (es)
PA (1) PA8549801A1 (es)
PE (1) PE20030239A1 (es)
PL (1) PL373891A1 (es)
SK (1) SK15802003A3 (es)
TN (1) TNSN03154A1 (es)
UY (1) UY27365A1 (es)
WO (1) WO2003004052A1 (es)
YU (1) YU102103A (es)
ZA (1) ZA200309747B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
EP2121721A4 (en) * 2006-09-07 2010-10-06 Boehringer Ingelheim Vetmed GENOTYPING BASED ON PCR
SI2066340T1 (sl) 2006-09-11 2013-11-29 Zoetis P Llc Toplotno obdelani bakterini in emulzijska cepiva, pripravljena iz takih toplotno obdelanih bakterinov
UY31437A1 (es) * 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
CA2729080C (en) * 2008-07-03 2018-09-11 Ricardo Rosenbusch Cattle vaccines
EP2362780B1 (en) * 2008-10-31 2019-12-25 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
CA2764424C (en) 2009-06-04 2019-12-31 National Institute Of Advanced Industrial Science And Technology Vaccine for mycoplasma infection
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
EP2938747B1 (en) 2012-12-28 2019-05-01 Boehringer Ingelheim Vetmedica GmbH Method of making a mycoplasma vaccine
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
LT3334454T (lt) 2015-08-14 2022-12-27 Zoetis Services Llc Mycoplasma bovis kompozicijos
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
US7943153B1 (en) * 1999-11-08 2011-05-17 Biomune Vaccines for Mycoplasma bovis and methods of use
DE29921392U1 (de) * 1999-12-06 2000-03-16 Felgentraeger & Co Oeko Chem U Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
WO2003004052A1 (en) 2003-01-16
HUP0501188A2 (en) 2006-05-29
MA27048A1 (fr) 2004-12-20
KR20040030783A (ko) 2004-04-09
EP1401488A1 (en) 2004-03-31
YU102103A (sh) 2006-05-25
AR036125A1 (es) 2004-08-11
GT200200139A (es) 2003-02-13
IS7078A (is) 2003-12-15
CA2452580A1 (en) 2003-01-16
CN1522152A (zh) 2004-08-18
CZ20033465A3 (cs) 2004-12-15
HRP20031078A2 (en) 2005-08-31
BR0210798A (pt) 2006-05-23
TNSN03154A1 (fr) 2005-12-23
AP2002002568A0 (en) 2002-06-30
SK15802003A3 (sk) 2005-01-03
PL373891A1 (en) 2005-09-19
HN2002000162A (es) 2002-09-17
PA8549801A1 (es) 2003-09-17
EA200301324A1 (ru) 2004-12-30
NO20035767L (no) 2004-01-30
IL159516A0 (en) 2004-06-01
ZA200309747B (en) 2005-05-27
US20030147914A1 (en) 2003-08-07
OA12640A (en) 2006-06-15
BG108496A (en) 2005-02-28
MXPA03011815A (es) 2004-04-02
PE20030239A1 (es) 2003-03-21
JP2004536106A (ja) 2004-12-02

Similar Documents

Publication Publication Date Title
UY27365A1 (es) Vacuna de mycoplasma bovis y métodos para reducir la neumonía en animales
AR034677A1 (es) Vacuna de mycoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado
UY27366A1 (es) Vacunación en dosis única con mycoplasma hyopneumoniae
BRPI0010612B8 (pt) vacinas
CY1120015T1 (el) Μεθοδοι χορηγησης εμβολιων
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
BRPI0614119B8 (pt) vacina para imunizar gatos contra calicivírus de felino
PT777499E (pt) Vacina viva para tratamento de doencas tumorais
US11975068B2 (en) Mesenchymal stem cells as vaccine adjuvants and methods for using the same
AR036355A1 (es) Modelo de exposicion a mycoplasma bovis, para evaluar la eficacia de potenciales vacunas
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
AR048671A1 (es) Procedimiento de vacunacion contra la infeccion testicular por bvdv
UY26763A1 (es) Inmunización del ganado lacteo con proteína gapc quimérica contra infección por estreptococo.
HRP20140447T1 (hr) Cjepivo koje sadrži ekstrakt ribosomskog proteina (rpe) i opcionalni th-1 promovirajuä†i adjuvans
MX2023005154A (es) Nanopartículas codificadas de adn y método de uso de las mismas como una vacuna contra la enfermedad corona virus (covid-19).
CY1116862T1 (el) Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae
Knottenbelt et al. Routine stud management procedures
WO2012042857A1 (ja) 粘膜アジュバント組成物
ES2172482B1 (es) Adicion de la patente es200100402 "vacuna para la proteccion de perros frente a la leishmania".
RU2213573C2 (ru) Способ профилактики паратифа телят
TH64472A (th) การให้วัคซีนขนาดยาเดียวที่มี Mycoplasma Hyopneumoniae
HN2002000163A (es) Vacunacion en dosis unica con mycoplasma hyopneumoniae
RU2000118399A (ru) Средство для профилактики инфекционного кератоконъюнктивита крупного рогатого скота и способы профилактики этого и других инфекционных заболеваний крупного рогатого скота (варианты)
TH76287A (th) ไวรัสไข้หัดในสัตว์ที่มีฟันเขี้ยวจำพวกสุนัขที่แยกได้ในเกาหลีและการใช้รีคอมบิแนนท์วัคซีนตัวเดียวกัน

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150826